Pathways: Strategies for susceptibility genes in SLE

Autoimmunity Reviews

Volumn 9, Issue 7, 2010, Pages 473-476

  Kelley, James M ^a   Edberg, Jeffrey C ^a   Kimberly, Robert P ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

Genetic association; Opsonin; Pathway; SLE

Indexed keywords

C REACTIVE PROTEIN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COLLECTIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; FC RECEPTOR; FICOLIN; MANNOSE BINDING LECTIN; OPSONIN; PENTRAXIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; CELL NUCLEUS ANTIGEN;

CHROMOSOME 9; COPY NUMBER VARIATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; OPSONIZATION; PATHOGENESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; ANTIGEN PRESENTATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; PHAGOCYTOSIS; SYSTEM ANALYSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NUCLEAR; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OPSONIN PROTEINS; PHAGOCYTOSIS; SYSTEMS ANALYSIS;

EID: 77951880754     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.02.003     Document Type: Review

References (39)

1. Kyogoku C., and Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 8 (2007) 445-455
2. Yao Y., Richman L., Higgs B.W., Morehouse C.A., de Los Reyes M., Brohawn P., et al. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60 (2009) 1785-1796
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
4. Dugoujon J.M., and Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22 (1995) 245-260
5. Schur P.H., Pandey J.P., and Fedrick J.A. Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum 28 (1985) 828-830
6. Lee E.B., Lee Y.J., Shin D.H., Choi Y.M., Park M.H., Pandey J.P., et al. Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus. Rheumatol Int 27 (2007) 219-224
7. Bredius R.G., de Vries C.E., Troelstra A., van Alphen L., Weening R.S., van de Winkel J.G., et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol 151 (1993) 1463-1472
8. Karassa F.B., Trikalinos T.A., and Ioannidis J.P. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46 (2002) 1563-1571
9. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 (2008) 204-210
10. Li X., Ptacek T.S., Brown E.E., and Edberg J.C. Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun 10 5 (2009) 380-389
11. Kono H., Kyogoku C., Suzuki T., Tsuchiya N., Honda H., Yamamoto K., et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 14 (2005) 2881-2892
12. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39 (2007) 721-723
13. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439 (2006) 851-855
14. Kawano M., Seya T., Koni I., and Mabuchi H. Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 116 (1999) 542-546
15. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22 (2004) 431-456
16. Agnello V. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum 21 (1978) S146-S152
17. Yang Y., Chung E.K., Wu Y.L., Savelli S.L., Nagaraja H.N., Zhou B., et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80 (2007) 1037-1054
18. Racila D.M., Sontheimer C.J., Sheffield A., Wisnieski J.J., Racila E., and Sontheimer R.D. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12 (2003) 124-132
19. Namjou B., Gray-McGuire C., Sestak A.L., Gilkeson G.S., Jacob C.O., Merrill J.T., et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun (2009)
20. Miyagawa H., Yamai M., Sakaguchi D., Kiyohara C., Tsukamoto H., Kimoto Y., et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 47 (2008) 158-164
21. Kurreeman F.A., Goulielmos G.N., Alizadeh B.Z., Rueda B., Houwing-Duistermaat J., Sanchez E., et al. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis 68 11 (2009) 1789-1790
22. Nishimoto K., Kochi Y., Ikari K., Yamamoto K., Suzuki A., Shimane K., et al. Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis 69 2 (2009) 368-373
23. Palomino-Morales R.J., Rojas-Villarraga A., Gonzalez C.I., Ramirez G., Anaya J.M., and Martin J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun 9 (2008) 379-382
24. Verma J., Arora V., Marwaha V., Kumar A., and Das N. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus. Lupus 14 (2005) 273-279
25. Douglas K.B., Windels D.C., Zhao J., Gadeliya A.V., Wu H., Kaufman K.M., et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun 10 5 (2009) 457-469
26. Wu H., Boackle S.A., Hanvivadhanakul P., Ulgiati D., Grossman J.M., Lee Y., et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci USA 104 (2007) 3961-3966
27. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 (2008) 900-909
28. Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P., Gilkeson G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40 (2008) 152-154
29. Lee Y.H., Witte T., Momot T., Schmidt R.E., Kaufman K.M., Harley J.B., et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 52 (2005) 3966-3974
30. Kristjansdottir H., Saevarsdottir S., Grondal G., Alarcon-Riquelme M.E., Erlendsson K., Valdimarsson H., et al. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families. Arthritis Rheum 58 (2008) 3865-3872
31. Seelen M.A., Trouw L.A., van der Hoorn J.W., Fallaux-van den Houten F.C., Huizinga T.W., Daha M.R., et al. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin Exp Immunol 134 (2003) 335-343
32. Keane M.P., and Lynch III J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 55 (2000) 159-166
33. Andersen T., Munthe-Fog L., Garred P., and Jacobsen S. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J Rheumatol 36 (2009) 757-759
34. Williams Jr. R.C., Harmon M.E., Burlingame R., and Du Clos T.W. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 32 (2005) 454-461
35. Russell A.I., Cunninghame Graham D.S., Shepherd C., Roberton C.A., Whittaker J., Meeks J., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13 (2004) 137-147
36. Edberg J.C., Wu J., Langefeld C.D., Brown E.E., Marion M.C., McGwin Jr. G., et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17 (2008) 1147-1155
37. Voss A., Nielsen E.H., Svehag S.E., and Junker P. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. Inverse association with anti-dsDNA antibodies. J Rheumatol 35 (2008) 625-630
38. Zandman-Goddard G., Blank M., Langevitz P., Slutsky L., Pras M., Levy Y., et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis 64 (2005) 1698-1702
39. Fazzini F., Peri G., Doni A., Dell'Antonio G., Dal Cin E., Bozzolo E., et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44 (2001) 2841-2850